此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Medsma℞t移动版

2026年10月7日 更新者:Olufunmilola Abraham

在急诊室中实施Medsma℞t家族:一种基于游戏的方法,用于改善青少年和父母的阿片类药物安全

The goal of this clinical trial is to learn if a new smartphone-based intervention can help with factors related to opioid misuse in parents and adolescent/early adult children. The main question it aims to answer is:

• Can this intervention improve knowledge of, and attitudes towards, opioid misuse over traditional opioid-related counseling alone?

Participants will, in addition to receiving opioid counseling:

  • Join an online meeting with research staff to test the smartphone-based intervention
  • Report demographic information
  • Complete surveys about opioids
  • Complete a family medication safety plan
  • Complete surveys after 3, 6, and 9 months

研究概览

研究类型

介入性

注册 (估计的)

244

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

学习地点

    • Illinois
      • Rockford、Illinois、美国、61104
    • Wisconsin
      • Madison、Wisconsin、美国、53792
        • University Hospital
        • 接触:
        • 首席研究员:
          • Allie Hurst, MD
      • Madison、Wisconsin、美国、53718
        • East Madison Hospital
        • 接触:
        • 接触:
          • Kayla Zubke
          • 电话号码:608-421-7367

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

12年 及以上 (孩子、成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Adults who receive an opioid prescription from a study Emergency Department, AND
  • who report having an adolescent, aged 12-18, living at home, AND
  • who speak and understand English
  • Each participant must have the ability to provide informed consent

Exclusion Criteria:

  • Adults who do not receive an opioid prescription from a study Emergency Department AND/OR
  • who do not have an adolescent, aged 12-18, living at home, AND/OR
  • who do not speak or understand English
  • Adults and/or adolescents who do not have the ability to provide informed consent

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:其他
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:单身的

武器和干预

参与者组/臂
干预/治疗
实验性的:Intervention

This group will receive the intervention of interest, MedSMA℞T Mobile, in addition to standard opioid-related counseling. MedSMA℞T Mobile is a serious game (intended to educate while entertaining) focused on opioid safety.

MedSMA℞T Mobile is an innovative mobile digital health intervention that integrates technology-based learning to facilitate family communication and creation of a personalized Family Medication Safety Plan. The Family Medication Safety Plan (FMSP) is a tool for families to record important information about their medications and create a plan for safe use, storage, and disposal. Participants will play MedSMA℞T Mobile for up to 30 minutes at the first study visit.

无干预:Control

This group will receive the standard opioid-related counseling that all patients receive when newly prescribed opioids in the emergency department.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Change in Adolescent Opioid Safety and Learning (AOSL) scale score over 9 month study
大体时间:Baseline, 3, 6, and 9 months.

The fourth factor of the Adolescent Opioid Safety and Learning (AOSL) scale, Opioid Harm, measures understanding of negative social and professional effects of opioid misuse. Scores range from 3-15, where 3 indicates the lowest level of overall opioid harm awareness and 15 is the highest level.

Baseline, 3, 6, and 9 months.

次要结果测量

结果测量
措施说明
大体时间
Change in Safe Opioid Storage Behaviour over 9 months
大体时间:Baseline, 3, 6, and 9 months.

This outcome contains 4 items from the Wisconsin Strategic Prevention Framework Partnerships for Success Community Survey - V02, comprised of yes/no questions. The minimum score for this scale is 0 (indicating least safe opioid storage behaviour) and the maximum is 4 (indicating most safe opioid storage behaviour).

Baseline, 3, 6, and 9 months.
Change in Opioid Disposal Behaviour over 9 months
大体时间:Baseline, 3, 6, and 9 months.

This outcome contains 6 items from the Wisconsin Strategic Prevention Framework Partnerships for Success Community Survey - V02, and includes yes/no questions. The minimum score for this scale is 0 (indicating least safe opioid disposal behaviour) and the maximum is 6 (indicating most safe opioid disposal behaviour).

Baseline, 3, 6, and 9 months.
Change in Medication Understanding and Use Self-Efficacy (MUSE) scale scores over 9 months
大体时间:Baseline, 3, 6, and 9 months.

This section covers the second factor, Learning About Medication, of the Medication Understanding and Use Self-Efficacy (MUSE) scale. This factor is comprised of 4 items, each scored 1-4. The minimum score is 4, and the maximum is 16. A score of 4 indicates lower understanding and self-efficacy in opioid use, whereas a score of 16 indicates highest level of understanding and self-efficacy in opioid use.

Baseline, 3, 6, and 9 months.
Change in Family Communication Behaviour Patterns over 9 months
大体时间:Baseline, 3, 6, and 9 months.

This includes both the parent and child versions of the 26-item, 2-factor scales. The first factor, Conversation orientation, contains 15 items. The second factor, Conformity orientation, contains 11 items. Items are scored from 1-5, where 1 is "Disagree Strongly" and 5 is "Agree Strongly". Scale scores are averages for the two scales, with each item contributing equally. The minimum and maximum average scores, therefore, cannot exceed 1 and 5, respectively.

Baseline, 3, 6, and 9 months.

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Olufunmilola Abraham, PhD、University of Kentucky College of Pharmacy

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (估计的)

2027年8月1日

初级完成 (估计的)

2027年12月1日

研究完成 (估计的)

2027年12月1日

研究注册日期

首次提交

2025年2月21日

首先提交符合 QC 标准的

2025年2月21日

首次发布 (实际的)

2025年2月27日

研究记录更新

最后更新发布 (实际的)

2026年10月9日

上次提交的符合 QC 标准的更新

2026年10月7日

最后验证

2026年10月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅